121 related articles for article (PubMed ID: 27423379)
1. The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients.
Chan JK; Gardner AB; Chan JE; Guan A; Alshak M; Kapp DS
Gynecol Oncol; 2016 Sep; 142(3):446-51. PubMed ID: 27423379
[TBL] [Abstract][Full Text] [Related]
2. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.
Fuh KC; Shin JY; Kapp DS; Brooks RA; Ueda S; Urban RR; Chen LM; Chan JK
Gynecol Oncol; 2015 Mar; 136(3):491-7. PubMed ID: 25455734
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
[TBL] [Abstract][Full Text] [Related]
4. Relationship status and other demographic influences on survival in patients with ovarian cancer.
Gardner AB; Sanders BE; Mann AK; Liao CI; Eskander RN; Kapp DS; Chan JK
Int J Gynecol Cancer; 2020 Dec; 30(12):1922-1927. PubMed ID: 32920535
[TBL] [Abstract][Full Text] [Related]
5. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis.
Wushou A; Jiang YZ; Liu YR; Shao ZM
Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033
[TBL] [Abstract][Full Text] [Related]
6. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
7. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.
Kapp DS; Shin JY; Chan JK
Cancer; 2008 Feb; 112(4):820-30. PubMed ID: 18189292
[TBL] [Abstract][Full Text] [Related]
9. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
10. The influence of conservative surgical practices for malignant ovarian germ cell tumors.
Chan JK; Tewari KS; Waller S; Cheung MK; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Aug; 98(2):111-6. PubMed ID: 18563734
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in survival among patients with germ cell tumors of the ovary--United States.
Bryant CS; Kumar S; Shah JP; Mahdi H; Ali-Fehmi R; Munkarah AR; Deppe G; Morris RT
Gynecol Oncol; 2009 Sep; 114(3):437-41. PubMed ID: 19560191
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
[TBL] [Abstract][Full Text] [Related]
13. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
14. Mature and immature teratoma: A report from the second Italian pediatric study.
Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G
Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333
[TBL] [Abstract][Full Text] [Related]
15. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
16. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
19. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012.
Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD
Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
